|
Market Closed -
Nasdaq
23:00:00 26/08/2026 +03
|
5-day change | 1st Jan Change | ||
| 11.12 USD | -4.79% |
|
+0.18% | -45.38% |
| 08-11 | BofA Securities Adjusts Keros Therapeutics Price Target to $17 From $20 | MT |
| 08-03 | Keros Therapeutics, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bullish | Bearish | Bearish |
| Resistance | 11.68 | 12.07 | 14.46 |
| Spread/Res. | -4.79% | -7.87% | -23.10% |
| Spread/Supp. | +3.15% | +12.21% | +10.54% |
| Support | 10.78 | 9.91 | 10.06 |
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- KROS Stock
- Charts Keros Therapeutics, Inc.
Select your edition
All financial news and data tailored to specific country editions
